Mutagenesis and cardiovascular diseases Molecular mechanisms, risk factors, and protective factors

被引:50
作者
De Flora, Silvio [1 ]
Izzotti, Alberto [1 ]
机构
[1] Univ Genoa, Dept Hlth Sci, I-16132 Genoa, Italy
关键词
atherosclerosis; mutation; DNA adducts; oxidative DNA damage; genetic polymorphisms; prevention;
D O I
10.1016/j.mrfmmm.2006.12.008
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Although no generalization can be made, it is of interest that cancer, cardiovascular diseases, and other chronic conditions often share common risk factors and common protective factors as well as common pathogenetic determinants, such as DNA damage, oxidative stress, and chronic inflammation. Atherosclerosis is the most important cause of vascular forms representing the major cause of death in the population of many geographical areas. A great deal of studies support the "response-to-injury" theory. A variety of experimental and epidemiological findings are also in favor of the somatic mutation theory, which maintains that the earliest event in the atherogenic process is represented by mutations in arterial smooth muscle cells, akin to formation of a benign tumor. These two theories can be harmonized, also taking into account the highly diversified nature of atherosclerotic lesions. Molecular epidemiology studies performed in our laboratory and other laboratories have shown that DNA adducts are systematically present in arterial smooth muscle cells, and their levels are correlated with atherogenic risk factors known from traditional epidemiology. Oxidative DNA damage was also consistently detected in these cells. The role of glutathione S-transferase polymorphisms on the frequency of the above molecular alterations and of arterial diseases is rather controversial. Prevention of both cancer and atherosclerosis is based on avoidance of exposure to risk factors and on fortification of the host defense mechanisms by means of dietary principles and chemopreventive drugs. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:5 / 17
页数:13
相关论文
共 90 条
[1]   THE CAUSES AND PREVENTION OF CANCER [J].
AMES, BN ;
GOLD, LS ;
WILLETT, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5258-5265
[2]  
Andreassi MG, 2000, ENVIRON MOL MUTAGEN, V35, P265, DOI 10.1002/1098-2280(2000)35:4<265::AID-EM1>3.0.CO
[3]  
2-M
[4]   Effects of chronic long-term therapy with calcium antagonists on cytogenetic damage in humans [J].
Andreassi, MG ;
Picano, E ;
Del Ry, S ;
Petrozzi, L ;
Giannessi, D ;
Varga, A .
JOURNAL OF HYPERTENSION, 1999, 17 (06) :843-846
[5]   Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage [J].
Andreassi, MG .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2003, 543 (01) :67-86
[6]  
[Anonymous], INT STAT CLASS DIS R
[7]  
Balansky R, 1996, CANCER RES, V56, P1642
[8]   EVIDENCE FOR A MONOCLONAL ORIGIN OF HUMAN ATHEROSCLEROTIC PLAQUES [J].
BENDITT, EP ;
BENDITT, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (06) :1753-1756
[9]   DNA-adducts and atherosclerosis:: a study of accidental and sudden death males in the Czech Republic [J].
Binková, B ;
Smerhovsky, Z ;
Strejc, P ;
Boubelík, O ;
Stávková, Z ;
Chvátalová, I ;
Srám, RJ .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2002, 501 (1-2) :115-128
[10]   Detection of the '4977 bp' mitochondrial DNA deletion in human atherosclerotic lesions [J].
Bogliolo, M ;
Izzotti, A ;
De Flora, S ;
Carli, C ;
Abbondandolo, A ;
Degan, P .
MUTAGENESIS, 1999, 14 (01) :77-82